FitLife Brands Return on Equity

FitLife Brands (FTLF) currently reports a ROE of 13.15%. That is below the Healthcare sector average of 20.86%. Use the charts on this page to explore FitLife Brands's ROE history and peer comparisons.

FitLife Brands's ROE of 13.15% is lower than the Healthcare sector average of 20.86%. That is roughly 36.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but FitLife Brands's current 13.15% should be judged against Healthcare norms (sector average: 20.86%) and against FTLF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 13.15%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.86%. From there, open related valuation or income-statement pages for FitLife Brands, and consider following FTLF for alerts when major investors trade the stock.

FitLife Brands is classified in the Healthcare sector. On ROE, it currently shows 13.15% versus a sector average near 20.86%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FTLF with unrelated industries.